12/25
06:03 am
mrna
Age of breakthroughs: More from The Globe and Mail [Globe and Mail, The (Toronto, Canada)]
Medium
Report
Age of breakthroughs: More from The Globe and Mail [Globe and Mail, The (Toronto, Canada)]
12/23
02:45 pm
mrna
Moderna: Why I Am Selling The 'Relief Rally' [Seeking Alpha]
Low
Report
Moderna: Why I Am Selling The 'Relief Rally' [Seeking Alpha]
12/19
08:05 pm
mrna
Moderna, Inc. (MRNA): A Bull Case Theory [Yahoo! Finance]
Medium
Report
Moderna, Inc. (MRNA): A Bull Case Theory [Yahoo! Finance]
12/17
10:11 am
mrna
HFA Architecture + Engineering Taps Sherwood Butler as Vice President [Yahoo! Finance]
Medium
Report
HFA Architecture + Engineering Taps Sherwood Butler as Vice President [Yahoo! Finance]
12/17
07:16 am
mrna
Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
12/12
12:00 pm
mrna
Moderna (NASDAQ:MRNA) was given a new $28.00 price target on by analysts at Morgan Stanley.
Low
Report
Moderna (NASDAQ:MRNA) was given a new $28.00 price target on by analysts at Morgan Stanley.
12/11
09:06 pm
mrna
Moderna (NASDAQ:MRNA) is now covered by analysts at Jefferies Financial Group Inc.. They set a "hold" rating on the stock.
Low
Report
Moderna (NASDAQ:MRNA) is now covered by analysts at Jefferies Financial Group Inc.. They set a "hold" rating on the stock.
12/9
09:25 am
mrna
Global AI Infrastructure Shift Ignites Biotech Growth Phase
Low
Report
Global AI Infrastructure Shift Ignites Biotech Growth Phase
12/1
11:04 am
mrna
Moderna (NASDAQ:MRNA) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Low
Report
Moderna (NASDAQ:MRNA) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
11/21
01:06 pm
mrna
Moderna (NASDAQ:MRNA) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Moderna (NASDAQ:MRNA) had its "buy" rating reaffirmed by analysts at UBS Group AG.
11/21
10:10 am
mrna
Moderna (NASDAQ:MRNA) was given a new $18.00 price target on by analysts at UBS Group AG.
Medium
Report
Moderna (NASDAQ:MRNA) was given a new $18.00 price target on by analysts at UBS Group AG.
11/21
09:47 am
mrna
Moderna (NASDAQ:MRNA) had its price target raised by analysts at Leerink Partners from $15.00 to $18.00. They now have an "underperform" rating on the stock.
Medium
Report
Moderna (NASDAQ:MRNA) had its price target raised by analysts at Leerink Partners from $15.00 to $18.00. They now have an "underperform" rating on the stock.
11/21
09:47 am
mrna
Moderna (NASDAQ:MRNA) had its price target lowered by analysts at Royal Bank Of Canada from $28.00 to $25.00. They now have a "sector perform" rating on the stock.
Medium
Report
Moderna (NASDAQ:MRNA) had its price target lowered by analysts at Royal Bank Of Canada from $28.00 to $25.00. They now have a "sector perform" rating on the stock.
11/21
09:09 am
mrna
Moderna (NASDAQ:MRNA) was given a new $63.00 price target on by analysts at Piper Sandler.
Medium
Report
Moderna (NASDAQ:MRNA) was given a new $63.00 price target on by analysts at Piper Sandler.
11/20
04:01 pm
mrna
Moderna (NASDAQ:MRNA) had its "underperform" rating reaffirmed by analysts at Wolfe Research.
Medium
Report
Moderna (NASDAQ:MRNA) had its "underperform" rating reaffirmed by analysts at Wolfe Research.
11/19
07:13 am
mrna
Moderna Expands U.S. Manufacturing with Onshoring of Drug Product Capabilities [Yahoo! Finance]
Medium
Report
Moderna Expands U.S. Manufacturing with Onshoring of Drug Product Capabilities [Yahoo! Finance]
11/17
07:02 am
mrna
Moderna (NASDAQ:MRNA) was given a new $28.00 price target on by analysts at Berenberg Bank.
Low
Report
Moderna (NASDAQ:MRNA) was given a new $28.00 price target on by analysts at Berenberg Bank.
11/10
08:03 am
mrna
Moderna (NASDAQ:MRNA) had its price target lowered by analysts at Bank of America Corporation from $24.00 to $21.00. They now have an "underperform" rating on the stock.
Low
Report
Moderna (NASDAQ:MRNA) had its price target lowered by analysts at Bank of America Corporation from $24.00 to $21.00. They now have an "underperform" rating on the stock.
11/7
11:10 am
mrna
Moderna (NASDAQ:MRNA) had its price target lowered by analysts at Barclays PLC from $31.00 to $25.00. They now have an "equal weight" rating on the stock.
Medium
Report
Moderna (NASDAQ:MRNA) had its price target lowered by analysts at Barclays PLC from $31.00 to $25.00. They now have an "equal weight" rating on the stock.
11/6
07:50 am
mrna
Moderna Gains on Sharp Cost Cuts as Covid Vaccine Declines [Yahoo! Finance]
Low
Report
Moderna Gains on Sharp Cost Cuts as Covid Vaccine Declines [Yahoo! Finance]
10/31
04:12 pm
mrna
Moderna: Focus On Cancer Vaccines, Not Buyout [Seeking Alpha]
Medium
Report
Moderna: Focus On Cancer Vaccines, Not Buyout [Seeking Alpha]
10/25
12:09 pm
mrna
Moderna (NASDAQ:MRNA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Moderna (NASDAQ:MRNA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/23
12:32 pm
mrna
Moderna (NASDAQ:MRNA) had its price target lowered by analysts at JPMorgan Chase & Co. from $26.00 to $25.00. They now have an "underweight" rating on the stock.
Low
Report
Moderna (NASDAQ:MRNA) had its price target lowered by analysts at JPMorgan Chase & Co. from $26.00 to $25.00. They now have an "underweight" rating on the stock.
10/23
08:42 am
mrna
Moderna (NASDAQ:MRNA) was given a new $40.00 price target on by analysts at UBS Group AG.
Low
Report
Moderna (NASDAQ:MRNA) was given a new $40.00 price target on by analysts at UBS Group AG.
10/23
08:07 am
mrna
Moderna (NASDAQ:MRNA) had its price target lowered by analysts at Citigroup Inc. from $30.00 to $28.00. They now have a "neutral" rating on the stock.
Low
Report
Moderna (NASDAQ:MRNA) had its price target lowered by analysts at Citigroup Inc. from $30.00 to $28.00. They now have a "neutral" rating on the stock.